vancomycin has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buttaro, MA; González Della Valle, AM; Mocetti, E; Morandi, AA; Piccaluga, F; Piñeiro, L | 1 |
| Benghuzzi, H; Conflitti, J; Dzugan, S; Galjour, C; Russell, G; Tsao, A; Tucci, M | 1 |
| Chan, EC; Chen, JK; Chi, PS; Lin, SS; Liu, SJ; Ueng, SW | 1 |
| Bumgardner, JD; Courtney, HS; Doty, HA; Haggard, WO; Leedy, MR | 1 |
| Bellary, SS; Hsu, EL; Hsu, WK; Kannan, AS; Mendoza, MC; Mitchell, SM; Park, C; Singh, G; Sonn, KA; Stock, SR; Yun, C | 1 |
5 other study(ies) available for vancomycin and transforming growth factor beta
| Article | Year |
|---|---|
Incorporation of vancomycin-supplemented bone incorporation of vancomycin-supplemented bone allografts: radiographical, histopathological and immunohistochemical study in pigs.
Topics: Animals; Anti-Bacterial Agents; Bone Transplantation; Collagenases; Fibrosis; Immunohistochemistry; Male; Matrix Metalloproteinase 13; Necrosis; Swine; Tibia; Transforming Growth Factor beta; Transforming Growth Factor beta2; Vancomycin; Wound Healing | 2003 |
Sustained release of OP-1 and antibiotics in treatment of femoral defects in male rats.
Topics: Animals; Anti-Bacterial Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Drug Combinations; Drug Implants; Femoral Fractures; Fracture Healing; Male; Osteitis; Osteogenesis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Treatment Outcome; Vancomycin | 2005 |
Novel solvent-free fabrication of biodegradable poly-lactic-glycolic acid (PLGA) capsules for antibiotics and rhBMP-2 delivery.
Topics: Animals; Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Capsules; Delayed-Action Preparations; Enzyme-Linked Immunosorbent Assay; Glycolates; Humans; Lactic Acid; Microbial Sensitivity Tests; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Recombinant Proteins; Staphylococcus aureus; Technology, Pharmaceutical; Transforming Growth Factor beta; Vancomycin | 2007 |
Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2.
Topics: Absorbable Implants; Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Substitutes; Calcium Sulfate; Chitosan; Diffusion; Drug Combinations; Drug Implants; Intercellular Signaling Peptides and Proteins; Materials Testing; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta; Vancomycin | 2014 |
The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Bone Development; Bone Morphogenetic Protein 2; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Female; Lumbar Vertebrae; Powders; Rats, Sprague-Dawley; Recombinant Proteins; Spinal Fusion; Surgical Wound; Surgical Wound Infection; Transforming Growth Factor beta; Treatment Outcome; Vancomycin; Wound Healing | 2016 |